This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1984 Feb 4;1(8371):276-7.

doi: 10.1016/s0140-6736(84)90145-4.

Not so benign long-term immunosuppression in multiple sclerosis?

F Lhermitte, R Marteau, E Roullet

PMID: 6143013
DOI: 10.1016/s0140-6736(84)90145-4

Not so benign long-term immunosuppression in multiple sclerosis?

F Lhermitte et al. Lancet. 1984.

. 1984 Feb 4;1(8371):276-7.

doi: 10.1016/s0140-6736(84)90145-4.

Authors

F Lhermitte, R Marteau, E Roullet

PMID: 6143013
DOI: 10.1016/s0140-6736(84)90145-4

No abstract available

PubMed Disclaimer

Similar articles

On cancer incidence in multiple sclerosis and effects of immunomodulatory treatments.
Feigin PD. Feigin PD. Breast Cancer Res Treat. 2005 Jul;92(2):197. doi: 10.1007/s10549-005-1687-7. Breast Cancer Res Treat. 2005. PMID: 15986130 No abstract available.
[CARIMS (Cancer Risk In Multiple Sclerosis) project: impact of long-term treatment].
Lebrun C, Debouverie M, Vermersch P, Clavelou P, Rumbach L, de Seze J, Defer G, Berthier F; Club Francophone de la Sclérose en Plaques. Lebrun C, et al. Rev Neurol (Paris). 2007 Jan;163(1):38-46. doi: 10.1016/s0035-3787(07)90353-7. Rev Neurol (Paris). 2007. PMID: 17304171 Review. French.
[Immunosuppressive treatments].
Tanaka M. Tanaka M. Nihon Rinsho. 2015 Sep;73 Suppl 7:212-5. Nihon Rinsho. 2015. PMID: 26480702 Japanese. No abstract available.
Medications for Multiple Sclerosis and Risk of Malignancy: What Next?
Horton DB, Reder AT. Horton DB, et al. Neurotherapeutics. 2021 Jul;18(3):1650-1653. doi: 10.1007/s13311-021-01107-5. Epub 2021 Aug 18. Neurotherapeutics. 2021. PMID: 34409568 Free PMC article. Review.
Cancer risk among patients with multiple sclerosis and their parents.
Hofer S, Linnebank M, Weller M, Bahmanyar S, Montgomery SM, Hillert J, Ekbom A, Olsson T. Hofer S, et al. Neurology. 2010 Feb 16;74(7):614-5; author reply 615. doi: 10.1212/WNL.0b013e3181c777b7. Neurology. 2010. PMID: 20157167 No abstract available.

See all similar articles

Cited by

Azathioprine for people with multiple sclerosis.
Ridley B, Nonino F, Baldin E, Casetta I, Iuliano G, Filippini G. Ridley B, et al. Cochrane Database Syst Rev. 2024 Dec 9;12(12):CD015005. doi: 10.1002/14651858.CD015005.pub2. Cochrane Database Syst Rev. 2024. PMID: 39651635 Free PMC article.
Evaluation of the risk of cervical cancer in patients with Multiple Sclerosis treated with cytotoxic agents: A cohort study.
Doosti R, Togha M, Moghadasi AN, Aghsaie A, Azimi AR, Khorramnia S, Moinfar Z, Ensani F, Harirchian MH, Minagar A, Sahraian MA. Doosti R, et al. Iran J Neurol. 2018 Apr 4;17(2):64-70. Iran J Neurol. 2018. PMID: 30210730 Free PMC article.
Risk factors for tumor occurrence in patients with myasthenia gravis.
Citterio A, Beghi E, Millul A, Evoli A, Mantegazza R, Antozzi C, Baggi F, Cornelio F, Durelli L, Clerico M, Piccolo G, Cosi V. Citterio A, et al. J Neurol. 2009 Aug;256(8):1221-7. doi: 10.1007/s00415-009-5091-9. Epub 2009 Mar 29. J Neurol. 2009. PMID: 19330280
Role of immunosuppressive therapy for the treatment of multiple sclerosis.
Stankiewicz JM, Kolb H, Karni A, Weiner HL. Stankiewicz JM, et al. Neurotherapeutics. 2013 Jan;10(1):77-88. doi: 10.1007/s13311-012-0172-3. Neurotherapeutics. 2013. PMID: 23271506 Free PMC article. Review.
A double blind study on azathioprine efficacy in multiple sclerosis: final report.
Milanese C, La Mantia L, Salmaggi A, Eoli M. Milanese C, et al. J Neurol. 1993 May;240(5):295-8. doi: 10.1007/BF00838165. J Neurol. 1993. PMID: 8326334 Clinical Trial.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information